NCT00886990 - Efficacy and Safety of Single Versus Double Ritonavir-boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens | Biotech Hunter

Enrollment

240

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions

HIV InfectionHIV Infections

Interventions

DRUG

ritonavir-boosted PI-based second line treatments

single PI boosted by low dose ritonavir

DRUG

two PIs boosted by low dose ritonavir or one PI plus full dose ritonavir

Trial Locations (8)

HIV-NAT, Bangkok

Petchburi Hospital, Petchburi

Queen Sirikit National Institute of Child Health, Bangkok

Siriraj Hospital, Mahidol University, Bangkok

Department of Pediatrics, Faculty of Medicine, Chiang Mai University Hospital, Chiang Mai

Chiang Rai Regional Hospital, Chiang Rai

Khon Kaen University, Khon Kaen

Bamrasnaradura Institute, Nonthaburi

All Listed Sponsors

collaborator

Ministry of Education, Thailand

OTHER

lead

The HIV Netherlands Australia Thailand Research Collaboration

OTHER